A multicenter real-world study from four Chinese hospitals evaluated long-term outcomes of a watch-and-wait strategy in stage II/III dMMR/MSI-H colorectal cancer patients who achieved endoscopic complete response after neoadjuvant anti-PD-1 monotherapy. (Frontiers in Immunology)
Watch-and-Wait After Neoadjuvant Anti-PD-1 in dMMR/MSI-H CRC
The CRC Digest